Trial intelligence / Profile preview

Alitretinoin versus azathioprine for severe chronic non-hyperkeratotic hand eczema

2015-001447-37Phase 3Active

Sponsor
University Medical Center Groningen
Start
Jun 2015
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in chronic hand dermatitis (CHE) comparing Oral alitretinoin with Oral azathioprine (2 arms). Primary endpoint: Treatment response at 24 weeks. Started Jun 2015; status: active.

02

Drugs

alitretinoinazathioprine
03

Conditions

chronic hand dermatitis (CHE)

Beyond the preview

Go deeper on 2015-001447-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001447-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call